<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>We report on the first screening round in the District of Ferrara, a region of Emilia-Romagna, carried out between March 2005 and March 2007 to illustrate the effort of <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>) screening from administration and information to therapy and follow-up </plain></SENT>
<SENT sid="1" pm="."><plain>After invitation of 38 344 persons aged 50-69 years (28.5%), 19 480 (50.8%) accepted the immunological faecal occult blood test, with 1 149 (6%) resulting positive </plain></SENT>
<SENT sid="2" pm="."><plain>One thousand and one individuals (88.2%) who tested positive for immunological faecal occult blood test accepted examination by either colonoscopy (99.5%) or <z:chebi fb="8" ids="32594,32595">barium</z:chebi> enema (0.5%) </plain></SENT>
<SENT sid="3" pm="."><plain>Out of 996 screenees having a colonoscopy, 231 had low-risk <z:mpath ids='MPATH_270'>adenomas</z:mpath> (23.2%) and 239 had high-risk <z:mpath ids='MPATH_270'>adenomas</z:mpath> (24%), and were treated endoscopically (96%) or surgically (4%) </plain></SENT>
<SENT sid="4" pm="."><plain>Ninety-one <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e> were diagnosed in 9.1% of colonoscopies (Dukes stadia: A, 58.2%; B, 19.8%; C, 18.7%; D, 3.3%) </plain></SENT>
<SENT sid="5" pm="."><plain>Fourteen <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e> (<z:hpo ids='HP_0000001'>all</z:hpo> in <z:mpath ids='MPATH_491'>polyps</z:mpath>) were treated endoscopically, and the remaining 77 were treated by surgery </plain></SENT>
<SENT sid="6" pm="."><plain>One Dukes B patient and 13 of 17 Dukes C patients received adjuvant chemotherapy </plain></SENT>
<SENT sid="7" pm="."><plain>Three Dukes D patients had chemotherapy only </plain></SENT>
<SENT sid="8" pm="."><plain>During the 2-year study period, 87 screenees had a follow-up colonoscopy: no <z:hpo ids='HP_0002664'>neoplasia</z:hpo> was found in 35 patients initially diagnosed with <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e>; low-risk <z:mpath ids='MPATH_270'>adenomas</z:mpath> were found in 31 of 52 patients with initial high-risk <z:mpath ids='MPATH_270'>adenomas</z:mpath> </plain></SENT>
<SENT sid="9" pm="."><plain>In conclusion, the first <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> screening round in Ferrara was easy to organize, had a high acceptance, and detected 91 cancers (78% of which were in Dukes stages A and B, compared with only 40% in <z:hpo ids='HP_0003745'>sporadic</z:hpo> <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> in the same background population) </plain></SENT>
<SENT sid="10" pm="."><plain>Chemotherapy was necessary in 17 cases </plain></SENT>
<SENT sid="11" pm="."><plain>This report may motivate other health authorities to initiate <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> screening campaigns </plain></SENT>
</text></document>